50-12-103. Availability of experimental drugs, MCA

Montana Code Annotated 2023

TITLE 50. HEALTH AND SAFETY

CHAPTER 12. TREATMENTS FOR CHRONIC OR TERMINAL ILLNESS

Part 1. Right to Try Act

Availability Of Experimental Drugs

50-12-103. Availability of experimental drugs. (1) A manufacturer of an investigational drug, biological product, or device may make the drug, product, or device available to a patient who has requested the drug, product, or device pursuant to this part.

(2) The manufacturer may:

(a) provide an investigational drug, biological product, or device to a patient without receiving compensation; or

(b) require a patient to pay the costs of or the costs associated with the manufacture of the investigational drug, biological product, or device.

(3) A manufacturer is not required to make an investigational drug, biological product, or device available to a patient.

History: En. Sec. 3, Ch. 135, L. 2015; amd. Sec. 2, Ch. 413, L. 2023.